Cerenome (CNSY) Director Clowes Howard Converts 921 RSUs

What Happened

• Clowes Howard, a director of Cerenome, reported the conversion/vesting of 921 restricted stock units (RSUs) on October 1, 2026. The Form 4 shows 921 shares acquired by conversion of a derivative (transaction code M) at $0.00 and a simultaneous disposition of 921 shares at $0.00. The filing reports no cash paid for the conversion.

Key Details

• Transaction date: 2026-10-01; transaction code: M (exercise/conversion of derivative).
• Shares acquired: 921 at $0.00; Shares disposed: 921 at $0.00 (both reported same day).
• Footnote F1: Each RSU converts to one share of common stock. Footnote F2: These RSUs vest in four substantially equal quarterly installments beginning July 1, 2026.
• Shares owned after transaction: Not specified in the reported excerpt.
• Filing timeliness: Reported same day (Period of Report and filing date both 2026-10-01), so not marked late.

Context

• This was a vesting/conversion of RSUs (an award), not a cash purchase or open-market sale. Form 4 entries that show concurrent acquisition and disposition of vested RSUs sometimes reflect share delivery, tax withholding, or internal transfers; the filing does not specify the reason for the reported disposition. This type of vesting is a routine compensation event rather than a direct bullish or bearish market signal.